About Enjosim
Enjosim specializes in the R&D, manufacturing, and sales of self-delivery systems, particularly those for biomacromolecule pharmaceuticals.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B
Global Headquarters
Shanghai
Tracked Since
Nov 2, 2026
Web & Domain Identity
Official Website
enjosim.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $30,080,000 · Series-B
Backed by CICC
Investors & Backers
CICC
Lead
Addor Capital
Co-Stone Venture Capital
HosenCare Brothers
Jiayuan Capital
Maotai Jianxin (Guizhou) Investment Fund
Qiming Venture Partners
Wuxi Yingyue Private Equity Fund Management
Yinman Venture Capital
Zhuhai Science and Technology Industry Group
Funding History
Series-B equity
· Nov 2, 2026
Round backers: CICC
$30,080,000 donews.com
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
INFevo
infevo.ai
Seed Beijing · Nov 2026
Seawolf Therapeutics
seawolftx.com
Seed San Diego · Nov 2026